This content is from:xinyabo体育app Health Care - Pharmaceuticals/Specialty: 2011 Third Marc Goodman lands in third place for a second straight year — and for the third time in four years. October 11, 2011
This content is from:xinyabo体育app Health Care – Pharmaceuticals/Speciality: 2012 Second Gregory Gilbert of Bank of America Merrill Lynch takes second place for a fourth year in a row. October 16, 2012
This content is from:365亚博 Deals of the Year 2014: Actavis Realizes Bigger Pharma Ambitions For CEO Brenton Saunders, the $66 billion friendly takeover of Allergan is just the latest in a string of health care mergers. ByAnne Szustek December 10, 2014
This content is from:365亚博 Actavis CEO Brent Saunders Has a Vision for Growth Once Actavis completes its merger with Allergan, CEO Brenton Saunders will need to focus on getting the two companies’ cultures and strategies on the same page. ByAnne Szustek March 12, 2015
This content is from:Premium How ValueAct Shook Off Its Big Loss from Valeant The hedge fund firm, headed by Jeff Ubben, did not suffer the same fate as other major shareholders of the ailing pharmaceutical concern. ByStephen Taub January 06, 2017
This content is from:Premium Funds Benefit from Merger-Happy Health Care Stocks Viking Global, Glenview Capital and Visium profit as stocks like Actavis, Anthem and Cigna rise on takeover fever. ByStephen Taub June 23, 2015
